Suite 300 235 West 15th Street
West Vancouver, BC V7T 2X1
Full Time Employees:
|Dr. William V. Williams M.D.||CEO, Pres & Director||710.99k||N/A||1957|
|Mr. Gadi Levin B.Com., C.A., CPA, M.B.A., MBA||CFO & Corp. Sec.||247.09k||N/A||1973|
|Dr. Miguel A. Lopez-Lago||Chief Scientific Officer||246.62k||N/A||1969|
|Dr. Giuseppe Del Priore M.D., M.P.H., MPH||Chief Medical Officer||438.86k||N/A||1962|
|Dr. Charles Louis Wiseman FACP, M.D.||Founder, Principal Research Advisor & Member of Scientific Advisory Board||N/A||N/A||1946|
BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development agreement with the National Cancer Institute to conduct preclinical studies to develop and test Bria-OTS cellular immunotherapy as a treatment for cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.